Yasin Keshvargar
Lawyers
Filters
GH Research $117.5 million follow-on offering
We advised GH Research on the offering
Avalyn Pharma $300 million IPO
We advised the underwriters on the IPO
Vistra $4 billion senior notes offering
We advised the representatives of the several underwriters on the offering
Revolution Medicines $2.2 billion common stock and convertible notes offerings
We advised the underwriters on the concurrent offerings
Ormat Technologies $1 billion convertible senior notes offering
We advised the representatives of the several initial purchasers on the offering
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Solid Biosciences $240 million private placement
We advised the lead placement agents
Korro Bio $85 million private placement
We advised the placement agents
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
Revolution Medicines $1 billion at-the-market offering
We advised the sales agent on the offering